Form N-23C-2 Calamos Global Dynamic For: Jul 24
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
NOTIFICATION OF REDEMPTION OF SECURITIES PURSUANT TO
RULE 23C-2 UNDER THE INVESTMENT COMPANY ACT OF 1940
Investment Company Act file number: 811-22047
CALAMOS GLOBAL DYNAMIC INCOME FUND
(Exact Name of the Registrant as Specified in Charter)
2020 Calamos Court
Naperville, Illinois 60563-2787
(Address of Principal Executive Office - Zip Code)
The undersigned registered closed-end investment company hereby notifies the Securities and Exchange Commission (“Commission”) that it will redeem securities of which it is the issuer, as set forth below in accordance with the requirements of Rule 23c-2 under the Investment Company Act of 1940 (the “Act”).
(1) Title of Class of Securities of Calamos Global Dynamic Income Fund (“Fund”) to be Redeemed:
Series D Mandatory Redeemable Preferred Shares (CUSIP — 12811L3*6), each with a liquidation preference of $25.00 per share (the “Series D Shares”).
(2) Date(s) on Which the Securities may be Redeemed:
The date fixed for redemption is August 24, 2026.
(3) Applicable Provisions of the Governing Instrument Pursuant to Which the Securities may be Redeemed:
The Series D Shares are being redeemed pursuant to Section 3(a) of the Calamos Global Dynamic Income Fund Statement of Preferences of Series D Mandatory Redeemable Preferred Shares and Series E Mandatory Redeemable Preferred Shares.
(4) Number of Shares and the Basis Upon Which the Securities that may be Redeemed are to be Selected:
The Fund will redeem 100% (200,000) of the outstanding Series D Shares.
SIGNATURE
Pursuant to Rule 23c-2 under the Act, the Fund has caused this Notification of Redemption of Securities to be duly executed on its behalf by the undersigned in the City of Naperville and the State of Illinois on this 24th day of July, 2026.
| CALAMOS GLOBAL DYNAMIC INCOME FUND | ||
| By: | /s/ Erik D. Ojala | |
| Name: | Erik D. Ojala | |
| Title: | Vice President and Secretary | |
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sonorous Neurovascular Achieves First Canadian Enrollment in B-SILENT Study, Expanding Global Momentum
- Growth of 150% in One Year: How BirBir Became Central Asia’s Fastest-Growing Classifieds Platform
- Niagen Bioscience Selects Global Drug Development Pioneer Evotec to Advance Preclinical Development for NB4168
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share